FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   BONIUK MILTON 2. Date of Event Requiring Statement (Month/Day/Year) 05/28/2013 3. Issuer Name and Ticker or Trading Symbol NANOVIRICIDES, INC. [NNVC] (Last) (First) (Middle) C/O NANOVIRICIDES, INC., 135 WOOD STREET, SUITE 205 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) WEST HAVEN, CT 06516 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock, par value $0.001 per share 200,000 (1) D   Common Stock, par value $0.001 per share 666,667 (2) I Held by Boniuk Charitable Foundation Common Stock, par value $0.001 per share 666,667 (3) I Held by Boniuk Investments Ltd

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	  (4)	06/30/2014	Common Stock, par value $0.001 per share	100,000	$ 1	D	Â
Unsecured 8% Coupon Series B Convertible Debenture	  (5)	01/31/2017	Common Stock, par value $0.001 per share	(7)	$ 1	I	Held by Boniuk Charitable Foundation
Unsecured 8% Coupon Series B Convertible Debenture	  (6)	01/31/2017	Common Stock, par value $0.001 per share	(7)	$ 1	I	Held by Boniuk Investments Ltd

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
BONIUK MILTON C/O NANOVIRICIDES, INC. 135 WOOD STREET, SUITE 205 WEST HAVEN, CT 06516	  X	Â	Â	Â

Signatures

/s/ Milton Boniuk		07/02/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 200,000 shares of common stock held in the name of the Reporting Person and his wife, Laurie Boniuk.
(2)	Includes 666,667 shares of common stock held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.
(3)	Includes 666,667 shares of common stock held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.
(4)	The warrants are presently exercisable and are held in the name of the Reporting Person and his wife, Laurie Boniuk.
(5)	The debenture is presently exercisable and is held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.
(6)	The debenture is presently exercisable and is held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.
(7)	The debentures are convertible into shares of the Issuer's Common Stock, at a conversion price of $1.00 per share plus interest in shares of restricted Common Stock.
  Remarks: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.